N0287

NNC 55-0396 hydrate

≥98% (HPLC)

• Sinónimos: (1S,2S)-2-(2-(N-[(3-Benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride hydrate, NNC55-0396
• Fórmula empírica (notación de Hill): C₃₀H₄₀Cl₂FN₃O₂ · xH₂O
• Peso molecular: 564.56 (anhydrous basis)
• MDL number: MFCD12910446
• UNSPSC Code: 12352200
• PubChem Substance ID: 24278523
• NACRES: NA.77

Propiedades

• assay: ≥98% (HPLC)
• form: solid
• storage condition: desiccated
• color: white
• solubility: H₂O: >10 mg/mL
• originator: Roche
• storage temp.: 2-8°C
• SMILES string: O.Cl.Cl.CC(C)[C@H]1c2ccc(F)cc2CC[C@@]1(CCN(C)CCCc3nc4ccccc4[nH]3)OC(=O)C5CC5
• InChI: 1S/C30H38FN3O2.2ClH.H2O/c1-20(2)28-24-13-12-23(31)19-22(24)14-15-30(28,36-29(35)21-10-11-21)16-18-34(3)17-6-9-27-32-25-7-4-5-8-26(25)33-27;;;/h4-5,7-8,12-13,19-21,28H,6,9-11,14-18H2,1-3H3,(H,32,33);2*1H;1H2/t28-,30-;;;/m0.../s1
• Inchi Key: ICVIUVXDXJUZRQ-SHQDEPIZSA-N

Descripción

Biochem/physiol Actions

NNC-55-0396 is a T-type calcium channel antagonists. It is the structural analog of mibefradil. NNC-55-0396 has the ability to block cell proliferation and stimulate cell apoptosis in leukemia cell lines.

Selective T-type calcium channel inhibitor

Features and Benefits

This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Información de seguridad

• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)